OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
M. Ishrat Husain, Daniel M. Blumberger, David Castle, et al.
BJPsych Open (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 18
M. Ishrat Husain, Daniel M. Blumberger, David Castle, et al.
BJPsych Open (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 18
Showing 18 citing articles:
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 29
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 29
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 3
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 3
Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 2
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access | Times Cited: 2
The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?
Bryan Barksdale, Manoj K. Doss, Gregory A. Fonzo, et al.
Neurotherapeutics (2024), pp. e00322-e00322
Open Access | Times Cited: 13
Bryan Barksdale, Manoj K. Doss, Gregory A. Fonzo, et al.
Neurotherapeutics (2024), pp. e00322-e00322
Open Access | Times Cited: 13
The intensity of the psychedelic experience is reliably associated with clinical improvements: a systematic review and meta-analysis
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access | Times Cited: 1
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 172, pp. 106086-106086
Closed Access | Times Cited: 1
The ketamine chameleon: history, pharmacology, and the contested value of experience
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Danny Diep, Sara de la Salle, Julien Thibault Lévesque, et al.
Expert Review of Clinical Pharmacology (2025)
Closed Access
Pharmacokinetics of Psilocybin: A Systematic Review
Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 411-411
Open Access
Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 411-411
Open Access
Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats
Zitong Wang, Brett Robbins, R. L. Zhuang, et al.
Research Square (Research Square) (2025)
Closed Access
Zitong Wang, Brett Robbins, R. L. Zhuang, et al.
Research Square (Research Square) (2025)
Closed Access
Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review
Margery J.Q. Chen, David Chen‐Li, Noah Chisamore, et al.
Psychiatry Research (2025) Vol. 349, pp. 116532-116532
Open Access
Margery J.Q. Chen, David Chen‐Li, Noah Chisamore, et al.
Psychiatry Research (2025) Vol. 349, pp. 116532-116532
Open Access
Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon
Val Bellman
Cancers (2024) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 3
Val Bellman
Cancers (2024) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 3
Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 829-829
Open Access | Times Cited: 3
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 829-829
Open Access | Times Cited: 3
Assessing potential of psilocybin for depressive disorders
Zofia Kozak, Matthew W. Johnson, Scott T. Aaronson
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 887-900
Closed Access | Times Cited: 8
Zofia Kozak, Matthew W. Johnson, Scott T. Aaronson
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 10, pp. 887-900
Closed Access | Times Cited: 8
A Critical View on New and Future Antidepressants
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2024) Vol. 22, Iss. 2, pp. 201-210
Open Access | Times Cited: 2
Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders
Jeetendra Kumar Gupta, Kuldeep Singh, Alok Bhatt, et al.
3 Biotech (2024) Vol. 14, Iss. 11
Closed Access | Times Cited: 2
Jeetendra Kumar Gupta, Kuldeep Singh, Alok Bhatt, et al.
3 Biotech (2024) Vol. 14, Iss. 11
Closed Access | Times Cited: 2
Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis
Mattia Marchi, Riccardo Farina, Karim Rachedi, et al.
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 1
Mattia Marchi, Riccardo Farina, Karim Rachedi, et al.
Journal of Psychopharmacology (2024)
Closed Access | Times Cited: 1
Neural effects of psychedelics: Complexity the key word
Brett D. M. Jones, M. Ishrat Husain
Neuropsychopharmacology (2024) Vol. 49, Iss. 7, pp. 1067-1068
Closed Access
Brett D. M. Jones, M. Ishrat Husain
Neuropsychopharmacology (2024) Vol. 49, Iss. 7, pp. 1067-1068
Closed Access
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey
Omer A. Syed, Rotem Petranker, Emily C. Fewster, et al.
Journal of Psychoactive Drugs (2024), pp. 1-11
Closed Access
Omer A. Syed, Rotem Petranker, Emily C. Fewster, et al.
Journal of Psychoactive Drugs (2024), pp. 1-11
Closed Access
